InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by GARDNER JASON, Autre. Insider active across 1 company, notably Magenta Therapeutics, Inc.. Cumulatively, 6 disclosures have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €164k. Activity tracked since 14 September 2021. The latest transaction was filed on 30 November 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
3,000 shares@ US$0.941.6% of flowCommon StockSEC:0000899243-22-037431:0
3,000 shares@ US$0.991.7% of flowCommon StockSEC:0000899243-22-021184:0
14,340 shares@ US$6.7349.2% of flowCommon StockSEC:0000899243-21-036599:0
14,340 shares@ US$6.7348.4% of flowCommon StockSEC:0000899243-21-036599
50,000 shares0Common StockSEC:0000899243-21-036335
50,000 shares0Common StockSEC:0000899243-21-036335:0
6 of 6 declarations
About GARDNER JASON
Jason Gardner is a senior executive at Magenta Therapeutics, Inc. He holds a leadership position in international optimization and strategic initiatives. His role is essential in guiding the company in its innovation and transformation efforts.
